NO20021564L - Tert.-butyl-(7-metyl-imidazo[1,2-a]pyridin-3-yl)-amin- derivater - Google Patents

Tert.-butyl-(7-metyl-imidazo[1,2-a]pyridin-3-yl)-amin- derivater

Info

Publication number: NO20021564L
Authority: NO; Norway
Prior art keywords: imidazo; pyridin; tert; butyl; methyl
Prior art date: 1999-10-08

Application number

NO20021564A

Other languages

English (en)

Norwegian (no)

Other versions

NO20021564D0 (no

Inventor

Corinna Maul

Bernd Sundermann

Hagen-Heinrich Hennies

Johannes Schneider

Matthias Gerlach

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

2002-04-03

Publication date

2002-06-04

2002-04-03 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2002-04-03 Publication of NO20021564D0 publication Critical patent/NO20021564D0/no

2002-06-04 Publication of NO20021564L publication Critical patent/NO20021564L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Psychology (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Obesity (AREA)
Endocrinology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20021564A 1999-10-08 2002-04-03 Tert.-butyl-(7-metyl-imidazo[1,2-a]pyridin-3-yl)-amin- derivater NO20021564L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19948434A DE19948434A1 (de)	1999-10-08	1999-10-08	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
PCT/EP2000/009791 WO2001027109A2 (de)	1999-10-08	2000-10-06	Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate

Publications (2)

Publication Number	Publication Date
NO20021564D0 NO20021564D0 (no)	2002-04-03
NO20021564L true NO20021564L (no)	2002-06-04

Family

ID=7924888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021564A NO20021564L (no)	1999-10-08	2002-04-03	Tert.-butyl-(7-metyl-imidazo[1,2-a]pyridin-3-yl)-amin- derivater

Country Status (28)

Country	Link
US (1)	US6703404B2 (es)
EP (1)	EP1218378B1 (es)
JP (1)	JP2003511450A (es)
KR (1)	KR100793619B1 (es)
CN (1)	CN1208336C (es)
AR (2)	AR025959A1 (es)
AT (1)	ATE238304T1 (es)
AU (2)	AU7419900A (es)
BR (1)	BR0014827A (es)
CA (1)	CA2386804A1 (es)
CO (2)	CO5210861A1 (es)
CZ (1)	CZ20021241A3 (es)
DE (2)	DE19948434A1 (es)
DK (1)	DK1218378T3 (es)
ES (1)	ES2198355T3 (es)
HK (1)	HK1047749B (es)
HU (1)	HUP0203545A3 (es)
IL (3)	IL148997A0 (es)
MX (1)	MXPA02003546A (es)
NO (1)	NO20021564L (es)
NZ (1)	NZ518438A (es)
PE (2)	PE20010706A1 (es)
PL (1)	PL355109A1 (es)
PT (1)	PT1218378E (es)
RU (1)	RU2002110281A (es)
SK (1)	SK4622002A3 (es)
WO (2)	WO2001027119A2 (es)
ZA (2)	ZA200203581B (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
CN1585639A (zh)	1998-09-21	2005-02-23	佛罗里达大学研究基金会	抗疟疾制剂
AU2001251444A1 (en)	2000-04-10	2001-10-23	Merck And Co., Inc.	Inhibitors of prenyl-protein transferase
DE10043845A1 (de) *	2000-09-06	2002-03-14	Gruenenthal Gmbh	Verfahren zur Messung der Aktivität der NO-Synthase
DE10050663A1 (de) *	2000-10-13	2002-04-18	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
EP1343785A2 (de) *	2000-12-13	2003-09-17	Basf Aktiengesellschaft	Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
DE10117184A1 (de) *	2001-04-05	2002-10-17	Gruenenthal Gmbh	Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10117183A1 (de) *	2001-04-05	2002-10-10	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
DE10132726A1 (de) *	2001-07-05	2003-02-27	Gruenenthal Gmbh	Verwendung von substituierten gamma-Lactonverbindungen als Arzneimittel
ATE434610T1 (de)	2002-03-13	2009-07-15	Euro Celtique Sa	Aryl substituierte pyrimidine und deren verwendung
US6919340B2 (en)	2002-04-19	2005-07-19	Cellular Genomics, Inc.	Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
US20050197435A1 (en) *	2002-06-14	2005-09-08	Dotson Darin L.	Polymer additive compositions for bimolecular nucleation in thermoplastics
WO2004022562A1 (en)	2002-09-09	2004-03-18	Cellular Genomics, Inc.	6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
DE10246890A1 (de)	2002-10-08	2004-04-22	Grünenthal GmbH	Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine
AU2003290333A1 (en) *	2002-12-24	2004-07-22	Biofocus Plc	Compound libraries of imidazo(1,5-a)pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
US7189723B2 (en)	2003-02-10	2007-03-13	Cgi Pharmaceuticals, Inc.	Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
WO2005014599A1 (en)	2003-06-04	2005-02-17	Cellular Genomics, Inc.	Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds
WO2005005429A1 (en)	2003-06-30	2005-01-20	Cellular Genomics, Inc.	Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
US7259164B2 (en)	2003-08-11	2007-08-21	Cgi Pharmaceuticals, Inc.	Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
AU2003270473A1 (en)	2003-09-09	2005-04-27	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
DE102004021716A1 (de) *	2004-04-30	2005-12-01	Grünenthal GmbH	Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
DE102004044884A1 (de)	2004-09-14	2006-05-24	Grünenthal GmbH	Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
WO2006034473A2 (en)	2004-09-23	2006-03-30	Reddy Us Therapeutics, Inc.	Novel pyrimidine compounds, process for their preparation and compositions containing them
BRPI0610644B8 (pt)	2005-04-04	2021-05-25	Univ Florida	composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
DE102005016547A1 (de) *	2005-04-08	2006-10-12	Grünenthal GmbH	Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
WO2007024294A2 (en)	2005-05-03	2007-03-01	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
MX2007014510A (es)	2005-05-20	2008-02-05	Array Biopharma Inc	Compuestos inhibidores de raf y metodos de uso de los mismos.
US8093401B2 (en)	2005-08-04	2012-01-10	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US8088928B2 (en)	2005-08-04	2012-01-03	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
ES2431050T3 (es)	2005-08-04	2013-11-22	Sirtris Pharmaceuticals, Inc.	Benzotiazoles y tiazolopiridinas como moduladores de la sirtuína
US7855289B2 (en)	2005-08-04	2010-12-21	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US7709468B2 (en)	2005-09-02	2010-05-04	Abbott Laboratories	Imidazo based heterocycles
DK1973545T3 (da)	2005-12-23	2013-02-25	Ariad Pharma Inc	Bicykliske heteroarylforbindelser
DE102006011574A1 (de)	2006-03-10	2007-10-31	Grünenthal GmbH	Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
BRPI0708823B1 (pt)	2006-03-17	2022-01-18	Ambit Biosciences Corporation	Composto, e, composição
CA2680592C (en)	2007-03-15	2016-07-05	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues and uses thereof in treating pathological conditions
WO2008134553A1 (en) *	2007-04-26	2008-11-06	Xenon Pharmaceuticals Inc.	Methods of using bicyclic compounds in treating sodium channel-mediated diseases
GB0708188D0 (en) *	2007-04-27	2007-06-06	Merck Sharp & Dohme	Therapeutic compounds
CL2008001822A1 (es)	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
CL2008001821A1 (es)	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
DE102007040336A1 (de) *	2007-08-27	2009-03-05	Johann Wolfgang Goethe-Universität Frankfurt am Main	Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
PL2201018T3 (pl)	2007-09-19	2016-11-30		STAŁE POSTACIE ZAWIERAJĄCE N-(5-TERT-BUTYLOIZOKSAZOL-3-ILO)-N'-{4--[7-(2-MORFOLIN-4-YLOETOKSY)IMIDAZO[2,1-b][1,3]BENZOTIAZOL-2-ILO]FENYLO}MOCZNIK, ICH KOMPOZYCJE ORAZ ICH ZASTOSOWANIA
AU2009215191A1 (en)	2008-02-13	2009-08-20	Gilead Connecticut, Inc.	6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof
US8431603B2 (en) *	2008-04-15	2013-04-30	Eisai R&D Management Co., Ltd.	3-phenylpyrazolo[5,1-b]thiazole compounds
WO2010032195A1 (en)	2008-09-16	2010-03-25	Csir	Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
PE20120121A1 (es)	2008-12-08	2012-02-20	Gilead Connecticut Inc	Derivados de imidazopirazina como inhibidores de syk
BRPI0922225B1 (pt)	2008-12-08	2022-01-11	Gilead Connecticut, Inc.	Inibidores de syk imidazopirazina, composição farmacêutica, e uso do composto
US8450321B2 (en)	2008-12-08	2013-05-28	Gilead Connecticut, Inc.	6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
BRPI0922435A2 (pt)	2008-12-19	2018-09-11	Sirtris Pharmaceuticals Inc	"composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
KR101717809B1 (ko)	2010-03-11	2017-03-17	질레드 코네티컷 인코포레이티드	이미다조피리딘 ｓｙｋ 억제제
ES2761200T3 (es)	2011-12-16	2020-05-19	Univ Florida	Usos de análogos de 4'-desferritiocina
MX2014012741A (es)	2012-04-26	2015-04-13	Bristol Myers Squibb Co	Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activado de proteasa (par4) para tratamiento de agregacion plaquetaria.
BR112014026643B1 (pt)	2012-04-26	2023-03-07	Universite De Montreal	Derivados de imidazotiadiazol e imidazopirazina como inibidores de receptor 4 ativado por protease (par4) para o tratamento de agregação de plaqueta, seus usos e composição farmacêutica
SG11201406759YA (en)	2012-04-26	2014-11-27	Bristol Myers Squibb Co	Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
CA2884767A1 (en) *	2012-11-14	2014-05-22	Stephan Bachmann	Imidazopyridine derivatives
AU2014296308C1 (en)	2013-07-30	2018-09-13	Kronos Bio, Inc.	Polymorph of Syk inhibitors
UA115815C2 (uk)	2013-07-30	2017-12-26	Гіліад Коннектікут, Інк.	Склад на основі інгібіторів syk
CA2930966A1 (en)	2013-11-22	2015-05-28	University Of Florida Research Foundation, Inc.	Desferrithiocin analogs and uses thereof
CA2932726C (en)	2013-12-04	2019-06-04	Gilead Sciences, Inc.	Methods for treating cancers with entospletinib
TWI662037B (zh)	2013-12-23	2019-06-11	美商基利科學股份有限公司	脾酪胺酸激酶抑制劑
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
PT3105226T (pt)	2014-02-13	2019-11-06	Incyte Corp	Ciclopropilaminas como inibidores de lsd1
WO2015123437A1 (en)	2014-02-13	2015-08-20	Incyte Corporation	Cyclopropylamines as lsd1 inhibitors
ME03654B (me)	2014-02-13	2020-07-20	Incyte Corp	Ciklopropilamini kao lsd1 inhibitori
TW201613860A (en)	2014-02-13	2016-04-16	Incyte Corp	Cyclopropylamines as LSD1 inhibitors
US9617279B1 (en)	2014-06-24	2017-04-11	Bristol-Myers Squibb Company	Imidazooxadiazole compounds
US9598419B1 (en)	2014-06-24	2017-03-21	Universite De Montreal	Imidazotriazine and imidazodiazine compounds
WO2016007731A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyridines and imidazopyrazines as lsd1 inhibitors
WO2016007727A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en)	2014-07-10	2016-04-16	Incyte Corp	Imidazopyrazines as LSD1 inhibitors
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EP3169366A1 (en)	2014-07-14	2017-05-24	Gilead Sciences, Inc.	Combinations for treating cancers
AU2016243939B2 (en)	2015-04-03	2020-09-03	Incyte Holdings Corporation	Heterocyclic compounds as LSD1 inhibitors
JP2018515475A (ja)	2015-04-27	2018-06-14	ユニバーシティーオブフロリダリサーチファンデーション，インク．	代謝的にプログラムされた金属キレーターおよびその使用
KR102710120B1 (ko)	2015-08-12	2024-09-27	인사이트 홀딩스 코포레이션	Lsd1 저해제의 염
AR109452A1 (es)	2016-04-22	2018-12-12	Incyte Corp	Formulación farmacéutica de un inhibidor de lsd1 y método de tratamiento
WO2019014514A1 (en) *	2017-07-14	2019-01-17	University Of Massachusetts	HETEROCYCLIC COMPOUNDS AND USES THEREOF
CN115028640A (zh)	2017-08-25	2022-09-09	吉利德科学公司	Syk抑制剂的多晶型物
WO2019070943A1 (en) *	2017-10-04	2019-04-11	Dana-Farber Cancer Institute, Inc.	SMALL MOLECULE INHIBITION OF SALL4 TRANSCRIPTION FACTOR AND USES THEREOF
WO2020047198A1 (en)	2018-08-31	2020-03-05	Incyte Corporation	Salts of an lsd1 inhibitor and processes for preparing the same
CN113950479A (zh)	2019-02-22	2022-01-18	克洛诺斯生物股份有限公司	作为syk抑制剂的缩合吡嗪的固体形式
WO2024220541A1 (en) *	2023-04-18	2024-10-24	Kallyope, Inc.	Nk3 modulators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489755A (en) *	1966-08-03	1970-01-13	Pfizer & Co C	Imidazo (1,2-b) pyridazines
FR2463774A1 (fr) *	1979-08-21	1981-02-27	Yamanouchi Pharma Co Ltd	Derives du 2-phenylimidazo(2,1-b)benzothiazole
EP0068378B1 (en) *	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
EP0266890A1 (en) *	1986-10-07	1988-05-11	Yamanouchi Pharmaceutical Co. Ltd.	Imidazopyridine derivatives, their production, and pharmaceutical compositions containing them
FR2638161B1 (fr) *	1988-10-24	1991-01-11	Centre Nat Rech Scient	Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
JPH08333258A (ja) *	1994-12-14	1996-12-17	Japan Tobacco Inc	チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
GB9506188D0 (en) *	1995-03-27	1995-05-17	Fujisawa Pharmaceutical Co	Amidine derivatives
US5908842A (en) *	1995-12-08	1999-06-01	Merck & Co., Inc.	Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
WO1998006724A1 (en) *	1996-08-09	1998-02-19	Yamanouchi Pharmaceutical Co., Ltd.	Metabotropic glutamate receptor agonists
AUPP278498A0 (en) *	1998-04-03	1998-04-30	Australian Nuclear Science & Technology Organisation	Peripheral benzodiazepine receptor binding agents

1999
- 1999-10-08 DE DE19948434A patent/DE19948434A1/de not_active Withdrawn
2000
- 2000-09-18 WO PCT/EP2000/009098 patent/WO2001027119A2/de not_active Ceased
- 2000-09-18 AU AU74199/00A patent/AU7419900A/en not_active Abandoned
- 2000-09-18 IL IL14899700A patent/IL148997A0/xx not_active IP Right Cessation
- 2000-10-02 CO CO00074640A patent/CO5210861A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105250A patent/AR025959A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105251A patent/AR025960A1/es not_active Application Discontinuation
- 2000-10-06 AT AT00969439T patent/ATE238304T1/de active
- 2000-10-06 PE PE2000001062A patent/PE20010706A1/es not_active Application Discontinuation
- 2000-10-06 CZ CZ20021241A patent/CZ20021241A3/cs unknown
- 2000-10-06 DE DE50001911T patent/DE50001911D1/de not_active Expired - Lifetime
- 2000-10-06 CA CA002386804A patent/CA2386804A1/en not_active Abandoned
- 2000-10-06 PT PT00969439T patent/PT1218378E/pt unknown
- 2000-10-06 PL PL00355109A patent/PL355109A1/xx not_active IP Right Cessation
- 2000-10-06 NZ NZ518438A patent/NZ518438A/en not_active IP Right Cessation
- 2000-10-06 EP EP00969439A patent/EP1218378B1/de not_active Expired - Lifetime
- 2000-10-06 MX MXPA02003546A patent/MXPA02003546A/es active IP Right Grant
- 2000-10-06 BR BR0014827-0A patent/BR0014827A/pt not_active IP Right Cessation
- 2000-10-06 PE PE2000001063A patent/PE20010632A1/es not_active Application Discontinuation
- 2000-10-06 CO CO00076179A patent/CO5251429A1/es not_active Application Discontinuation
- 2000-10-06 HU HU0203545A patent/HUP0203545A3/hu unknown
- 2000-10-06 ES ES00969439T patent/ES2198355T3/es not_active Expired - Lifetime
- 2000-10-06 IL IL14899900A patent/IL148999A0/xx active IP Right Grant
- 2000-10-06 DK DK00969439T patent/DK1218378T3/da active
- 2000-10-06 WO PCT/EP2000/009791 patent/WO2001027109A2/de not_active Ceased
- 2000-10-06 SK SK462-2002A patent/SK4622002A3/sk unknown
- 2000-10-06 RU RU2002110281/04A patent/RU2002110281A/ru not_active Application Discontinuation
- 2000-10-06 JP JP2001530327A patent/JP2003511450A/ja active Pending
- 2000-10-06 HK HK02109385.2A patent/HK1047749B/zh not_active IP Right Cessation
- 2000-10-06 AU AU79153/00A patent/AU780526B2/en not_active Ceased
- 2000-10-06 KR KR1020027004518A patent/KR100793619B1/ko not_active Expired - Fee Related
- 2000-10-06 CN CNB008167079A patent/CN1208336C/zh not_active Expired - Fee Related
2002
- 2002-04-03 NO NO20021564A patent/NO20021564L/no not_active Application Discontinuation
- 2002-04-04 IL IL148999A patent/IL148999A/en not_active IP Right Cessation
- 2002-04-08 US US10/117,339 patent/US6703404B2/en not_active Expired - Fee Related
- 2002-05-06 ZA ZA200203581A patent/ZA200203581B/xx unknown
- 2002-05-06 ZA ZA200203579A patent/ZA200203579B/xx unknown

Also Published As

Publication number	Publication date
AR025959A1 (es)	2002-12-26
KR20020069003A (ko)	2002-08-28
ZA200203581B (en)	2004-02-25
EP1218378B1 (de)	2003-04-23
DK1218378T3 (da)	2003-07-21
ZA200203579B (en)	2003-10-29
CN1407983A (zh)	2003-04-02
AU7419900A (en)	2001-04-23
WO2001027119A2 (de)	2001-04-19
BR0014827A (pt)	2003-07-08
HK1047749B (zh)	2003-08-22
CN1208336C (zh)	2005-06-29
DE19948434A1 (de)	2001-06-07
AU7915300A (en)	2001-04-23
AU780526B2 (en)	2005-03-24
IL148999A (en)	2007-03-08
CO5251429A1 (es)	2003-02-28
RU2002110281A (ru)	2003-12-20
HUP0203545A2 (hu)	2003-02-28
IL148999A0 (en)	2002-11-10
HK1047749A1 (en)	2003-03-07
ATE238304T1 (de)	2003-05-15
KR100793619B1 (ko)	2008-01-11
HUP0203545A3 (en)	2004-07-28
PE20010632A1 (es)	2001-07-07
IL148997A0 (en)	2002-11-10
CA2386804A1 (en)	2001-04-19
JP2003511450A (ja)	2003-03-25
EP1218378A2 (de)	2002-07-03
AR025960A1 (es)	2002-12-26
WO2001027119A3 (de)	2001-10-11
SK4622002A3 (en)	2002-09-10
PT1218378E (pt)	2003-09-30
US20030022914A1 (en)	2003-01-30
WO2001027109A3 (de)	2001-09-20
PE20010706A1 (es)	2001-08-13
US6703404B2 (en)	2004-03-09
ES2198355T3 (es)	2004-02-01
NO20021564D0 (no)	2002-04-03
NZ518438A (en)	2004-08-27
MXPA02003546A (es)	2002-09-18
WO2001027109A2 (de)	2001-04-19
PL355109A1 (en)	2004-04-05
CZ20021241A3 (cs)	2002-08-14
DE50001911D1 (de)	2003-05-28
CO5210861A1 (es)	2002-10-30

Publication	Publication Date	Title
NO20021564L (no)	2002-06-04	Tert.-butyl-(7-metyl-imidazo[1,2-a]pyridin-3-yl)-amin- derivater
EE04964B1 (et)	2008-02-15	Imidaso[1,2a]pridiini ja prasolo[2,3a]pridiiniderivaadid
DE60016615D1 (de)	2005-01-13	Pyrazolo[4,3-d]pyrimidinderivate
DK1381363T3 (da)	2005-04-18	Imidazo[1,2-a]pyridinderivater som mGluR5-antagonister
IL191960A (en)	2015-11-30	History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
MA26851A1 (fr)	2004-12-20	Derives de pyrrolo [2,3-d] pyrimidine
AU7922900A (en)	2001-05-08	Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
NO20020391D0 (no)	2002-01-25	8-Fenyl-6,9-dihydro-[1,2,4]-triazolo-[3,4-i]-purin-5-on- derivater
DE69901379D1 (de)	2002-06-06	Camptothecin-Derivate mit Antitumor-Wirkung
NO20021379D0 (no)	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav
NO20043565L (no)	2004-11-25	Heteroaryl-substituerte 2-pyridinyl- og 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater.
DE60103909D1 (de)	2004-07-22	2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
NO20013384D0 (no)	2001-07-06	Imidazo[4,5-c]pyridin-4-on-derivater
DE50001191D1 (de)	2003-03-06	Pyrazolo[4, 3-d]pyrimidine
NO996045L (no)	1999-12-08	3-Substituerte pyrido[3',4':4,5]tieno[2,3-d]pyrimidin- derivater, fremstilling og anvendelse derav
AU2002224115A1 (en)	2002-06-11	1,4,5,6-tetrahydroimidazo(4,5-d)diazepine derivatives or salts thereof
SI1218378T1 (en)	2003-08-31	Tert.-butyl-(7-methyl-imidazo(1,2-a)pyridine-3-yl)-amine derivatives
PT1326866E (pt)	2005-08-31	3,4-di-hidropirido[1,2-a]pirimidinas substituidas
ZA200005185B (en)	2001-06-18	Indole-2,3-Dione-3-Oxime derivatives for therapeutic use.

Legal Events

Date	Code	Title	Description
2006-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application